Condensed Statements of Stockholders Equity - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning balance, shares at Dec. 31, 2017	22,803,533
Beginning balance, amount at Dec. 31, 2017	$ 2,280	$ 4,137,936	$ (1,067,901)	$ 3,072,315
Share-based compensation expense		172,973		172,973
Net loss for the period			(1,210,920)	(1,210,920)
Ending balance, shares at Jun. 30, 2018	22,803,533
Ending balance, amount at Jun. 30, 2018	$ 2,280	4,310,909	(2,278,821)	2,034,368
Beginning balance, shares at Mar. 31, 2018	22,803,533
Beginning balance, amount at Mar. 31, 2018	$ 2,280	4,137,936	(1,503,279)	2,636,937
Share-based compensation expense		172,973		172,973
Net loss for the period			(775,542)	(775,542)
Ending balance, shares at Jun. 30, 2018	22,803,533
Ending balance, amount at Jun. 30, 2018	$ 2,280	4,310,909	(2,278,821)	2,034,368
Beginning balance, shares at Dec. 31, 2018	27,364,607
Beginning balance, amount at Dec. 31, 2018	$ 2,736	16,791,254	(4,404,336)	12,389,654
Sale of common stock and warrants at $6.50 per share and placement agent warrants in public offering, net of issuance costs, shares	1,923,076
Sale of common stock and warrants at $6.50 per share and placement agent warrants in public offering, net of issuance costs, amount	$ 192	11,351,022		11,351,214
Common shares issued upon exercise of warrants at $3.00 per share, shares	62,150
Common shares issued upon exercise of warrants at $3.00 per share, amount	$ 6	186,444		186,450
Common shares issued upon exercise of warrants at $5.00 per share, shares	274,167
Common shares issued upon exercise of warrants at $5.00 per share, amount	$ 28	1,370,807		1,370,835
Common shares issued upon exercise of stock options, shares	16,250
Common shares issued upon exercise of stock options, amount	$ 2	24,373		24,375
Share-based compensation expense		600,898		600,898
Net loss for the period			(3,394,855)	(3,394,855)
Ending balance, shares at Jun. 30, 2019	29,640,250
Ending balance, amount at Jun. 30, 2019	$ 2,964	30,324,798	(7,799,191)	22,528,571
Beginning balance, shares at Mar. 31, 2019	27,364,607
Beginning balance, amount at Mar. 31, 2019	$ 2,736	17,018,301	(5,885,117)	11,135,920
Sale of common stock and warrants at $6.50 per share and placement agent warrants in public offering, net of issuance costs, shares	1,923,076
Sale of common stock and warrants at $6.50 per share and placement agent warrants in public offering, net of issuance costs, amount	$ 192	11,351,022		11,351,214
Common shares issued upon exercise of warrants at $3.00 per share, shares	62,150
Common shares issued upon exercise of warrants at $3.00 per share, amount	$ 6	186,444		186,450
Common shares issued upon exercise of warrants at $5.00 per share, shares	274,167
Common shares issued upon exercise of warrants at $5.00 per share, amount	$ 28	1,370,807		1,370,835
Common shares issued upon exercise of stock options, shares	16,250
Common shares issued upon exercise of stock options, amount	$ 2	24,373		24,375
Share-based compensation expense		373,851		373,851
Net loss for the period			(1,914,074)	(1,914,074)
Ending balance, shares at Jun. 30, 2019	29,640,250
Ending balance, amount at Jun. 30, 2019	$ 2,964	$ 30,324,798	$ (7,799,191)	$ 22,528,571